Clarifying new molecular subtyping and precise treatment of melanoma based on disulfidptosis-related lncRNA signature.

It is worth mentioning that although the high-risk group had worse prognosis in the M1 subgroup, it did not reach statistical significance, which could be attributed to the smaller sample size in the M1 clinical subgroup (Fig. 3 Q).

also in 111,027 other papers